ArticleMacromolecular rapid communications2026
Dual Functioning Deep Eutectic Solvents and Imidazolium-Based Ionic Liquids for Synergistic Toughening of Thermoset System.
Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A greener strategy for toughening thermoset epoxy resin by the combination of imidazolium based ionic liquid (IL) and a newly synthesized salicylic acid (HBA) and triethylenetetramine (HBD) based deep eutectic solvent (DES) is demonstrated in this work. DES served as both a fracture-toughening agent and curing activator for IL(1-butyl-3-methylimidazolium chloride, bromide, and 1-ethyl-3-methylimidazolium acetate) cured epoxy systems, outperforming the traditional triethylenetetramine (TETA)-cured systems. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) confirmed a single-phase curing mechanism, with a 30% increase in glass transition temperature (T
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.